Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Bone. 2012 Mar 19;50(6):1214–1222. doi: 10.1016/j.bone.2012.03.011

Figure 5. Serum Biomarkers.

Figure 5

Bar graphs displaying serum levels of: A) Alkaline phosphatase (ALP); B) Carboxy-terminal collagen crosslinks (CTX) and; C) Testosterone, for the three treatment groups (Water, MP-Low, and MP-High) analyzed immediately after 13 weeks of treatment (Standard) and following 5 weeks of untreated recovery (Recovery). Markers indicate group average with error bars denoting SEM. Results were compared between groups within each dosing protocol using ANOVA (ALP and Testosterone) and Kruskal-Wallis tests (CTX), followed by pairwise comparisons with Dunnett’s tests. All comparisons were considered significant for p-values < 0.05. Significant differences between groups are indicated by brackets and asterisks.